Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daryl Geers

Showing results (11-20 of 33) with videos related to

Pageof 4
Sort By:
The Journal of Infection|August 10, 2024
Fourth dose bivalent COVID-19 vaccines outperform monovalent boosters in eliciting cross-reactive memory B cells to Omicron subvariantsHolly A Fryer, Daryl Geers, Lennert Gommers, et al.
AIDS (London, England)|May 24, 2024
Immunogenicity of a bivalent BA.1 COVID-19 booster vaccine in people with HIV in the NetherlandsMarlou J Jongkees, Ngoc H Tan, Daryl Geers, et al.
Journal of Sleep Research|December 10, 2024
The effect of sleep and shift work on the primary immune response to messenger RNA-based COVID-19 vaccinationTamara M J Brouwers, Ümmü Gülsüm Çobanoğlu, Daryl Geers, et al.
The New England Journal of Medicine|January 19, 2022
Immunogenicity and Reactogenicity of Vaccine Boosters after Ad26.COV2.S PrimingRoos S G Sablerolles, Wim J R Rietdijk, Abraham Goorhuis, et al.
Frontiers in Immunology|December 16, 2022
Analyzing the immunogenicity of bivalent booster vaccinations in healthcare workers: The SWITCH ON trial protocolNgoc H Tan, Roos S G Sablerolles, Wim J R Rietdijk, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 20, 2022
Durability of Immune Responses After Boosting in Ad26.COV2.S-Primed Healthcare WorkersRoos S G Sablerolles, Wim J R Rietdijk, Abraham Goorhuis, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 7, 2022
Antibody and T-Cell Responses 6 Months After Coronavirus Disease 2019 Messenger RNA-1273 Vaccination in Patients With Chronic Kidney Disease, on Dialysis, or Living With a Kidney TransplantJan-Stephan F Sanders, A Lianne Messchendorp, Rory D de Vries, et al.
NPJ Vaccines|May 17, 2023
Th<sub>1</sub>-dominant cytokine responses in kidney patients after COVID-19 vaccination are associated with poor humoral responsesYvette den Hartog, S Reshwan K Malahe, Wim J R Rietdijk, et al.
Transplantation|June 21, 2024
Repeated COVID-19 Vaccination Drives Memory T- and B-cell Responses in Kidney Transplant Recipients: Results From a Multicenter Randomized Controlled TrialS Reshwan K Malahe, Yvette den Hartog, Wim J R Rietdijk, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|June 3, 2023
The role of interleukin-21 in COVID-19 vaccine-induced B cell-mediated immune responses in patients with kidney disease and kidney transplant recipientsS Reshwan K Malahe, Yvette den Hartog, Wim J R Rietdijk, et al.
Pageof 4

Showing results (11-20 of 33) with videos related to

Sort By:
Pageof 4
The Journal of Infection|August 10, 2024
Fourth dose bivalent COVID-19 vaccines outperform monovalent boosters in eliciting cross-reactive memory B cells to Omicron subvariantsHolly A Fryer, Daryl Geers, Lennert Gommers, et al.
AIDS (London, England)|May 24, 2024
Immunogenicity of a bivalent BA.1 COVID-19 booster vaccine in people with HIV in the NetherlandsMarlou J Jongkees, Ngoc H Tan, Daryl Geers, et al.
Journal of Sleep Research|December 10, 2024
The effect of sleep and shift work on the primary immune response to messenger RNA-based COVID-19 vaccinationTamara M J Brouwers, Ümmü Gülsüm Çobanoğlu, Daryl Geers, et al.
The New England Journal of Medicine|January 19, 2022
Immunogenicity and Reactogenicity of Vaccine Boosters after Ad26.COV2.S PrimingRoos S G Sablerolles, Wim J R Rietdijk, Abraham Goorhuis, et al.
Frontiers in Immunology|December 16, 2022
Analyzing the immunogenicity of bivalent booster vaccinations in healthcare workers: The SWITCH ON trial protocolNgoc H Tan, Roos S G Sablerolles, Wim J R Rietdijk, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 20, 2022
Durability of Immune Responses After Boosting in Ad26.COV2.S-Primed Healthcare WorkersRoos S G Sablerolles, Wim J R Rietdijk, Abraham Goorhuis, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 7, 2022
Antibody and T-Cell Responses 6 Months After Coronavirus Disease 2019 Messenger RNA-1273 Vaccination in Patients With Chronic Kidney Disease, on Dialysis, or Living With a Kidney TransplantJan-Stephan F Sanders, A Lianne Messchendorp, Rory D de Vries, et al.
NPJ Vaccines|May 17, 2023
Th<sub>1</sub>-dominant cytokine responses in kidney patients after COVID-19 vaccination are associated with poor humoral responsesYvette den Hartog, S Reshwan K Malahe, Wim J R Rietdijk, et al.
Transplantation|June 21, 2024
Repeated COVID-19 Vaccination Drives Memory T- and B-cell Responses in Kidney Transplant Recipients: Results From a Multicenter Randomized Controlled TrialS Reshwan K Malahe, Yvette den Hartog, Wim J R Rietdijk, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|June 3, 2023
The role of interleukin-21 in COVID-19 vaccine-induced B cell-mediated immune responses in patients with kidney disease and kidney transplant recipientsS Reshwan K Malahe, Yvette den Hartog, Wim J R Rietdijk, et al.
Pageof 4